Clinical Trials Browser

Withdrawn × Topotecan × Gynecologic × Clear all

NCT05295589 2023-09-26

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Phase 2 Withdrawn

Platinum-Refractory Fallopian Tube Carcinoma

NCT04943627 2022-10-05

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT02348398 2016-08-16

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms